argenx

Latest news

• European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading (opens in a new tab)

  MT Newswires · Oct 2, 2026

• argenx completes USD 77.00 acquisition. Forte Biosciences stock leaves Nasdaq (opens in a new tab)

  AD HOC NEWS · Oct 1, 2026

• argenx SE Stock 12‑Month Price Target Raised to $1206.02, Implies 26% Upside (opens in a new tab)

  TradingView · Oct 1, 2026

• argenx presents new VYVGART data for argenx stock (opens in a new tab)

  AD HOC NEWS · Oct 1, 2026

• Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT), Argenx Se (ARGX) and Obsidian Therapeutics (OBX) (opens in a new tab)

  theglobeandmail.com · Sep 30, 2026

• European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading (opens in a new tab)

  MT Newswires · Sep 30, 2026

• argenx stock falls 2.06 percent as VYVGART data arrive (opens in a new tab)

  AD HOC NEWS · Sep 30, 2026

• (ARGX) Risk Channels and Responsive Allocation (opens in a new tab)

  Stock Traders Daily · Sep 30, 2026

• Argenx to present new data across its portfolio, pipeline at 2026 AANEM (opens in a new tab)

  TipRanks · Sep 29, 2026

• BofA Securities Maintains Argenx SE(ARGX.US) With Buy Rating (opens in a new tab)

  Moomoo · Sep 29, 2026

• Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium (opens in a new tab)

  BioSpace · Sep 29, 2026

• Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA (opens in a new tab)

  TipRanks · Sep 29, 2026

• Treatment data for nerve and muscle conditions is on argenx (ARGX)’s conference agenda. (opens in a new tab)

  Stock Titan · Sep 29, 2026

• Argenx Presents New Vyvgart Data at AANEM and MGFA Congresses (opens in a new tab)

  Ideal Investisseur · Sep 29, 2026

• 
  argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline (opens in a new tab)

  GlobeNewswire · Sep 29, 2026

• No-Moat Argenx's Growth Led by Vyvgart; Pipeline Brings Long-Term Diversification (opens in a new tab)

  Morningstar · Sep 28, 2026

• Argenx Expands Kidney Pipeline With New IgA Nephropathy Trial (opens in a new tab)

  TipRanks · Sep 28, 2026

• argenx stock closes at EUR 844.60 on September 28, 2026, down 0.07 percent (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• argenx SE (CEUX:ARGXb) - Valuation Measures & Financial Statistics (opens in a new tab)

  GuruFocus · Sep 28, 2026

• argenx stock reports 60 percent Q2 sales growth now (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• argenx stock at EUR 845.20 on September 25, 2026, up 1.25 percent (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• 
  Here's Exactly Why Wall Street Thinks Argenx Stock Could Soar 23% Over the Next 12 Months (opens in a new tab)

  Motley Fool · Sep 26, 2026

• Will Board Refresh Change argenx Stock Narrative (opens in a new tab)

  Simply Wall Street · Sep 26, 2026

• Argenx Advances Empasiprubart Into Phase 2 for Guillain-Barré: What Investors Should Watch (opens in a new tab)

  TipRanks · Sep 25, 2026

• Argenx stock last at EUR 842.40, up 0.91 percent in Euronext trading (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• Argenx SE : Goldman Sachs remains its Buy rating (opens in a new tab)

  marketscreener.com · Sep 25, 2026

• Argenx shares head into the open after September 24 market data (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• argenx SE A (1AE.MU) Q2 FY2026 earnings call transcript (opens in a new tab)

  Yahoo Finance · Sep 25, 2026

• Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today (opens in a new tab)

  Benzinga · Sep 24, 2026

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Thursday Trading (opens in a new tab)

  Sep 24, 2026